Cite

HARVARD Citation

    Komiyama, S. et al. (2018). Platinum‐resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine. Journal of obstetrics and gynaecology research. 44 (7), pp. 1330-1334. [Online]. 
  
Back to record